| MR-LC-广州 | AstraZeneca | China | 2026-06-25 |
| MR-BC-成都 | AstraZeneca | China | 2026-06-25 |
| MR-GI-重庆 | AstraZeneca | China | 2026-06-25 |
| MR-GUGY-成都 | AstraZeneca | China | 2026-06-25 |
| MR-Hema-衡阳 | AstraZeneca | China | 2026-06-25 |
| MR-GUGY-惠州 | AstraZeneca | China | 2026-06-25 |
| MR-GUGY-广州 | AstraZeneca | China | 2026-06-25 |
| MR-GI-重庆 | AstraZeneca | China | 2026-06-25 |
| MR-BC-济南 | AstraZeneca | China | 2026-06-25 |
| Key Account Manager CVRM - Timisoara | AstraZeneca | Bucharest, Romania | 2026-06-25 |
| MR-LC-双鸭山 | AstraZeneca | China | 2026-06-25 |
| MR-突破性多适应症生物制剂-宝鸡 | AstraZeneca | China | 2026-06-25 |
| MR-突破性多适应症生物制剂-汉中 | AstraZeneca | China | 2026-06-25 |
| MR-突破性多适应症生物制剂-黄石 | AstraZeneca | China | 2026-06-25 |
| Key Account Manager Rare Diseases - Bucharest | AstraZeneca | Bucharest, Romania | 2026-06-25 |
| Therapy Area Specialist / Pharmareferent (m/w/d) Renal Metabolism Gebiet: Mannheim - Heidelberg - Sinsheim/Mosbach - Bensheim - Rüsselsheim (befristet für 12 Monate) | AstraZeneca | United Kingdom | 2026-06-25 |
| MR-GUGY-杭州 | AstraZeneca | China | 2026-06-25 |
| MR-Hema-上海 | AstraZeneca | China | 2026-06-25 |
| MR-Hema-武汉 | AstraZeneca | China | 2026-06-25 |
| MR-Hema-广州 | AstraZeneca | China | 2026-06-25 |
| MR-Hema-广州 | AstraZeneca | China | 2026-06-25 |
| MR-Hema-重庆 | AstraZeneca | China | 2026-06-25 |
| Therapy Area Specialist / Pharmareferent (m/w/d) Renal Metabolism Gebiet: Dresden - Pirna/Meißen - Görlitz | AstraZeneca | United Kingdom | 2026-06-25 |
| Pharmaceutical Sales Specialist, Advanced Specialty Care- Immunology Biologics- Los Angeles, CA | AstraZeneca | Los Angeles, United States | 2026-06-25 |
| MR-LC-合肥 | AstraZeneca | China | 2026-06-25 |
| MR-呼吸生物制剂新产品-盐城 | AstraZeneca | China | 2026-06-25 |
| Sales Representative- South District | Novo Nordisk | Kfar Saba, Israel | 2026-06-25 |
| 医药顾问-长春-肥胖症 | Novo Nordisk | Changchun, China | 2026-06-25 |
| 高级区域合规顾问-杭州 | Novo Nordisk | Hangzhou, China | 2026-06-25 |
| 高级医药代表-松原-创新胰岛素 | Novo Nordisk | Songyuan, China | 2026-06-25 |
| Pharma Field Sales - Cardiometabolic Care Specialist I - Hep/GI - Spokane Washington | Novo Nordisk | Spokane, United States | 2026-06-25 |
| 医药代表-广州-胰岛素 | Novo Nordisk | Guangzhou, China | 2026-06-25 |
| Pharma Field Sales - Cardiometabolic Care Specialist I - Hep Gi - Seattle Washington | Novo Nordisk | Seattle, United States | 2026-06-25 |
| 医药代表-天津-GLP-1-盈专职 | Novo Nordisk | Tianjin, China | 2026-06-25 |
| 医药代表-乌鲁木齐-GLP-1 | Novo Nordisk | China | 2026-06-25 |
| Sr Manager, Key Account | Novo Nordisk | Taipei, Taiwan | 2026-06-25 |
| 高级区域零售关键客户代表-大庆 | Novo Nordisk | Daqing, China | 2026-06-25 |
| Pharma Field Sales - Cardiometabolic Care Specialist I - P Elmira New York | Novo Nordisk | Elmira, United States | 2026-06-25 |
| Pharma Field Sales - Cardiometabolic Care Specialist I - P Corona California | Novo Nordisk | Corona, United States | 2026-06-25 |
| 医药顾问-上海-胰岛素 | Novo Nordisk | Shanghai, China | 2026-06-25 |
| 医药代表-上海-GLP-1 | Novo Nordisk | Chongqing, China | 2026-06-25 |
| 医药代表-乐山-胰岛素 | Novo Nordisk | Leshan, China | 2026-06-25 |
| 医药代表-新疆喀什-胰岛素 | Novo Nordisk | China | 2026-06-25 |
| 医药代表-天津-GLP-1-天津中医药大学第一附属医院 | Novo Nordisk | Tianjin, China | 2026-06-25 |
| Représentant Commercial 1 / 2 | Novo Nordisk | Québec, Canada | 2026-06-25 |
| 医药代表-宁德-胰岛素 | Novo Nordisk | Ningde, China | 2026-06-25 |